Laura Furmanski, Ph.D.
Partner, Head of Patient Square Insights
Laura Furmanski, Ph.D. is a Partner of Patient Square Capital and Head of Patient Square Insights. Dr. Furmanski has 22 years of health care experience across consulting and operating roles, most recently as Managing Director & Partner at Boston Consulting Group. While at BCG, Dr. Furmanski worked with biopharma and medical device companies on a range of R&D, market access, and broader strategy topics, and she played a lead role in creating BCG’s data and analytics offerings for the health care sector.
Prior to BCG, Dr. Furmanski created and was SVP and Head of the Bioinformatics Business Area for QIAGEN, a life science company. In that capacity, her team built and launched the company’s genomic clinical decision support platform for oncology and rare diseases. She managed the engineering and commercial teams that delivered a portfolio of innovative informatics products to biopharmaceutical companies, academic research institutions, and clinical labs. Dr. Furmanski was also a Partner at McKinsey & Co, where she worked across the entire health care value chain.
Dr. Furmanski currently serves on the board of directors of Apollo Therapeutics, Elevage Medical Technologies, Enavate Sciences, Radius Health, and Resolve Biosciences. She has also served on the board of several non-profit organizations focused on expanding health care services globally, including the American College of Medical Genetics and Genomics Foundation and ReSurge International.
Dr. Furmanski holds a Ph.D. in Cognitive Neuroscience from UCLA and a B.A. from Stanford University.
